comparemela.com

Page 2 - Denk Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jobberman Ghana

Mongolian team advances to final four of Vitality World Running Cup

The Mongolian team participating in the Vitality Running World Cup has won the third place in the second stage of the tournament and clinched its spot in the finals along with South Africa, Namibia and the United Kingdom.

| Channel5Belize com

| Channel5Belize com
channel5belize.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from channel5belize.com Daily Mail and Mail on Sunday newspapers.

NRx Pharmaceuticals Announces Initiation of Emergency Use Training and Extension of Phase 2/3 Inhaled ZYESAMI™ (Aviptadil-acetate) Trial in the Nation of Georgia

NRx Pharmaceuticals Announces Initiation of Emergency Use Training and Extension of Phase 2/3 Inhaled ZYESAMI™ (Aviptadil-acetate) Trial in the Nation of Georgia
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

MerLion Pharmaceuticals Completes Growth Financing Round

MerLion Pharmaceuticals Completes Growth Financing Round 05/18/2021 | 03:30am EDT Send by mail : Message : TM Berlin, (18/05/2021) - MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics for the treatment of serious bacterial infections, today announced the successful completion of a growth financing round raised via a private placement to European strategic investors. The funds raised will primarily be used to finance the production and market launch of MerLion’s US FDA and Health Canada approved drug Xtoro TM, an otic suspension containing finafloxacin for treatment of ear infections. In addition to existing investors such as HeidelbergCapital and Vl Partners, new strategic investors such as Denk Pharma GmbH & Co. KG have taken part in the round. Further details were not disclosed.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.